Orbitrap Excedion Pro BioPharma Mass Spectrometer and UHPLC 75F40126Q00088
Summary
AI-generated · May 02, 2026Acquire a high-resolution mass spectrometry system with integrated UHPLC to support regulatory-grade pharmaceutical quality evaluation and impurity characterization, including detection and characterization of nitrosamine impurities, small molecules, peptides, and other biomolecules. The reference brand is Thermo Scientific Orbitrap Excedion Pro BioPharma MS with UHPLC, and proposals may be brand-name or equal, provided they meet or exceed the salient characteristics: HRAM MS with sufficient resolving power for complex mixtures and trace impurities, a mass range up to approximately m/z 12,000, high sensitivity for trace impurities, compatibility with an integrated UHPLC, integrated instrument control and data analysis software for advanced workflows, automated data processing and spectral deconvolution, centralized data management for secure operation and workflow automation, delivery/installation and IQ/OQ, vendor-provided familiarization and operator training, and a minimum one-year manufacturer warranty starting upon Government acceptance.
Offers of equal equipment must clearly demonstrate how each salient characteristic is met or exceeded; the Government will evaluate brand-name or equal proposals accordingly.
The Government intends to acquire a high-resolution mass spectrometry system with ultra-high-performance liquid chromatography capability to support the analysis of pharmaceutical drug substances and drug products, including detection and characterization of nitrosamine impurities, small molecules, peptides, and other biomolecules. The Thermo Scientific Orbitrap Excedion Pro BioPharma MS and UHPLC system is referenced as the brand-name product used to define the level of performance and functionality required. This acquisition is conducted on a brand-name-or-equal basis. Products offered as an equal must meet or exceed the salient characteristics identified below in order to be considered technically acceptable. The Government requires an integrated LC-MS analytical system capable of supporting regulatory-grade analytical workflows for pharmaceutical quality evaluation and impurity characterization. The system must provide high-resolution, accurate-mass detection across a wide mass range to support both small molecule and biomolecule applications, including trace-level impurity detection and characterization of peptide-based therapeutics. At a minimum, the offered system shall meet the following salient characteristics: High-resolution accurate-mass (HRAM) mass spectrometry system capable of resolving complex mixtures and trace-level impurities in pharmaceutical samples Mass analyzer capable of achieving resolving power sufficient for high-confidence molecular identification and impurity characterization Extended mass range capability to analyze both small molecules and larger biomolecules (minimum mass range approximately up to m/z 12,000) Sensitivity sufficient for trace-level detection of pharmaceutical impurities, including nitrosamines Compatibility with an integrated ultra-high-performance liquid chromatography (UHPLC) system suitable for biocompatible analytical applications Integrated instrument control and data analysis software capable of supporting advanced analytical workflows for small molecule and peptide characterization Capability for automated data processing, spectral deconvolution, and identification workflows for complex pharmaceutical samples Centralized data management capability supporting secure instrument operation, workflow automation, and laboratory data integration Delivery, installation, and instrument qualification (IQ/OQ) services for the complete LC-MS system Vendor-provided instrument familiarization and operational training Minimum one (1) year manufacturer warranty covering parts, labor, travel, and OEM-certified service support, beginning upon Government acceptance of the system The Government will evaluate quotations offering the referenced brand-name product or equal products that meet the above salient characteristics. Offerors proposing an equal product must clearly demonstrate in their quotation how the proposed equipment meets or exceeds each of the required salient characteristics.
From Combined Synopsis/Solicitation posted on May 01, 2026Notice history
1-
Combined Synopsis/Solicitation LATEST Posted May 01, 2026
Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA